ACS Nano,
Journal Year:
2023,
Volume and Issue:
18(5), P. 4140 - 4158
Published: Dec. 22, 2023
Ischemic
stroke
is
one
of
the
major
causes
death
and
disability
worldwide,
an
effective
timely
treatment
ischemic
has
been
a
challenge
because
narrow
therapeutic
window
poor
affinity
with
thrombus
thrombolytic
agent.
In
this
study,
rPZDCu,
multifunctional
nanoparticle
(NP)
effects
thrombolysis,
reactive
oxygen
species
(ROS)
scavenging,
neuroprotection,
was
synthesized
based
on
ultrasmall
Cu
Advanced Materials,
Journal Year:
2023,
Volume and Issue:
36(10)
Published: Jan. 9, 2023
Abstract
Nanozymes
with
intrinsic
enzyme‐mimicking
activities
have
shown
great
potential
to
become
surrogates
of
natural
enzymes
in
many
fields
by
virtue
their
advantages
high
catalytic
stability,
ease
functionalization,
and
low
cost.
However,
due
the
lack
predictable
descriptors,
most
nanozymes
reported
past
been
obtained
mainly
through
trial‐and‐error
strategies,
efficacy,
substrate
specificity,
as
well
practical
application
effect
under
physiological
conditions,
are
far
inferior
that
enzymes.
To
optimize
efficacies
functions
biomedical
settings,
recent
studies
introduced
biosystem‐inspired
strategies
into
nanozyme
design.
In
this
review,
advances
engineering
leveraging
refined
structure
enzymes,
simulating
behavior
changes
process,
mimicking
specific
biological
processes
or
living
organisms,
introduced.
Furthermore,
currently
involved
applications
summarized.
More
importantly,
current
opportunities
challenges
design
discussed.
It
is
hoped
based
on
bioinspired
will
be
beneficial
for
constructing
new
generation
broadening
applications.
Journal of Nanobiotechnology,
Journal Year:
2022,
Volume and Issue:
20(1)
Published: June 14, 2022
As
Traditional
Chinese
Medicine
(TCM)
drugs,
Huangqi
and
Danshen
are
always
applied
in
combination
for
spinal
cord
injury
(SCI)
treatment
based
on
the
compatibility
theory
of
TCM.
Astragalus
Polysaccharidesis
(APS)
Tanshinone
IIA
(TSIIA)
main
active
ingredients
Danshen,
they
both
possess
neuroprotective
effects
through
antioxidant
activities.
However,
low
solubility
poor
bioavailability
have
greatly
limited
their
application.
In
recent
years,
selenium
nanoparticles
(SeNPs)
drawn
enormous
attention
as
potential
delivery
carrier
drugs.In
this
study,
TCM
ingredients-based
SeNPs
surface
decorated
with
APS
loaded
TSIIA
(TSIIA@SeNPs-APS)
were
successfully
synthesized
under
guidance
Such
design
improved
benefits
high
stability,
efficient
highly
therapeutic
efficacy
SCI
illustrated
by
an
improvement
protective
TSIIA.
The
vivo
experiments
indicated
that
TSIIA@SeNPs-APS
displayed
efficiency
cellular
uptake
long
retention
time
PC12
cells.
Furthermore,
had
a
satisfactory
effect
against
oxidative
stress-induced
cytotoxicity
cells
inhibiting
excessive
reactive
oxygen
species
(ROS)
production,
so
to
alleviate
mitochondrial
dysfunction
reduce
cell
apoptosis
S
phase
cycle
arrest,
finally
promote
survival.
can
protect
neurons
rats
enhancing
GSH-Px
activity
decreasing
MDA
content,
which
was
possibly
via
metabolism
SeCys2
regulating
selenoproteins
resist
damage.TSIIA@SeNPs-APS
exhibited
promising
anti-oxidation
therapy
SCI,
paved
way
developing
synergistic
nanotechnology
improve
well
establishing
novel
treatments
stress-related
diseases
associated
Se
regulation.
Angewandte Chemie International Edition,
Journal Year:
2023,
Volume and Issue:
62(33)
Published: April 21, 2023
Nanozymes,
nanomaterials
with
enzyme-mimicking
activity,
have
attracted
tremendous
interest
in
recent
years
owing
to
their
ability
replace
natural
enzymes
various
biomedical
applications,
such
as
biosensing,
therapeutics,
drug
delivery,
and
bioimaging.
In
particular,
the
nanozymes
capable
of
regulating
cellular
redox
status
by
mimicking
antioxidant
mammalian
cells
are
great
therapeutic
significance
oxidative-stress-mediated
disorders.
As
distinction
physiological
oxidative
stress
(oxidative
eustress)
pathological
distress)
occurs
at
a
fine
borderline,
it
is
challenge
design
that
can
differentially
sense
two
extremes
cells,
tissues
organs
mediate
appropriate
chemical
reactions.
this
Review,
we
summarize
advances
development
redox-active
applications.
We
primarily
highlight
prooxidant
disease
model
systems,
cancer,
neurodegeneration,
cardiovascular
diseases.
The
future
perspectives
emerging
area
research
challenges
associated
applications
described.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: Aug. 22, 2023
Radiation
colitis
is
the
leading
cause
of
diarrhea
and
hematochezia
in
pelvic
radiotherapy
patients.
This
work
advances
pathogenesis
radiation
from
perspective
ferroptosis.
An
oral
Pickering
emulsion
stabilized
with
halloysite
clay
nanotubes
to
alleviate
by
inhibiting
Ceria
nanozyme
grown
situ
on
can
scavenge
reactive
oxygen
species,
deferiprone
was
loaded
into
lumen
relieve
iron
stress.
These
two
strategies
effectively
inhibit
lipid
peroxidation
rescue
ferroptosis
intestinal
microenvironment.
The
play
a
critical
role
as
either
medicine
colitis,
nanocarrier
that
targets
inflamed
colon
electrostatic
adsorption,
or
an
interfacial
stabilizer
for
emulsions.
ferroptosis-based
strategy
effective
vitro
vivo,
providing
prospective
candidate
protection
via
rational
regulation
specific
oxidative
Advanced Science,
Journal Year:
2024,
Volume and Issue:
11(13)
Published: Jan. 26, 2024
Abstract
Developing
nanozymes
with
effective
reactive
oxygen
species
(ROS)
scavenging
ability
is
a
promising
approach
for
osteoarthritis
(OA)
treatment.
Nonetheless,
numerous
lie
in
their
relatively
low
antioxidant
activity.
In
certain
circumstances,
some
of
these
may
even
instigate
ROS
production
to
cause
side
effects.
To
address
challenges,
copper‐based
metal–organic
framework
(Cu
MOF)
nanozyme
designed
and
applied
OA
Cu
MOF
exhibits
comprehensive
powerful
activities
(i.e.,
SOD‐like,
CAT‐like,
•OH
activities)
while
negligible
pro‐oxidant
(POD‐
OXD‐like
activities).
Collectively,
more
at
various
types
than
other
Cu‐based
antioxidants,
such
as
commercial
CuO
single‐atom
nanozyme.
Density
functional
theory
calculations
also
confirm
the
origin
its
outstanding
enzyme‐like
activities.
vitro
vivo
results
demonstrate
that
an
excellent
decrease
intracellular
levels
relieve
hypoxic
microenvironment
synovial
macrophages.
As
result,
can
modulate
polarization
macrophages
from
pro‐inflammatory
M1
anti‐inflammatory
M2
subtype,
inhibit
degradation
cartilage
matrix
efficient
The
biocompatibility
protective
properties
make
it
valuable
asset
treating
ROS‐related
ailments
beyond
OA.
ACS Nano,
Journal Year:
2023,
Volume and Issue:
17(14), P. 14053 - 14068
Published: July 10, 2023
Easy
recurrence
and
strong
treatment
side
effects
significantly
limit
the
clinical
of
allergic
dermatitis.
The
human
trace
element
selenium
(Se)
plays
essential
roles
in
redox
regulation
through
incorporation
into
selenoproteins
form
21st
necessary
amino
acid
selenocysteine,
to
participates
pathogenesis
intervention
chronic
inflammatory
diseases.
Therefore,
based
on
safe
elemental
properties
Se,
we
construct
a
facile-synthesis
strategy
for
antiallergic
nanoparticles
(LET-SeNPs),
scale
up
production
by
employing
spray
drying
method
with
lactose
(Lac-LET-SeNPs)
or
maltodextrin
(Mal-LET-SeNPs)
as
encapsulation
agents
realizing
larger
longer
storage
time.
As
expected,
these
as-prepared
LET-SeNPs
could
effectively
activate
Nrf2-Keap1
signaling
pathway
enhance
expression
antioxidative
selenoprotein
at
mRNA
protein
levels,
then
inhibit
mast
cell
activation
achieve
efficient
activity.
Interestingly,
undergo
metabolism
seleno-amino
acids
promote
biosynthesis
selenoproteins,
which
suppress
ROS-induced
cyclooxygenase-2
(COX-2)
MAPKs
release
histamine
cytokines.
Allergic
mouse
Macaca
fascicularis
models
further
confirm
that
increase
Se
content
skin,
decrease
cells
infiltration,
finally
exhibit
high
therapeutic
Taken
together,
this
study
not
only
constructs
facile
large-scale
synthesis
translational
nanomedicine
break
bottleneck
problem
nanomaterials
but
also
sheds
light
its
application
allergies.
Advanced Science,
Journal Year:
2023,
Volume and Issue:
10(20)
Published: May 2, 2023
Following
stroke,
oxidative
stress
induced
by
reactive
oxygen
species
(ROS)
aggravates
neuronal
damage
and
enlarges
ischemic
penumbra,
which
is
devastating
to
stroke
patients.
Nanozyme-based
antioxidants
are
emerging
treat
through
scavenging
excessive
ROS.
However,
most
of
nanozymes
cannot
efficiently
scavenge
ROS
in
cytosol
mitochondria,
due
low-uptake
abilities
neurons
barriers
organelle
membranes,
significantly
limiting
nanozymes'
neuroprotective
effects.
To
overcome
this
limitation,
a
manganese-organic
framework
modified
with
polydopamine
(pDA-MNOF),
capable
not
only
mimicking
catalytic
activities
natural
SOD2's
domain
but
also
upregulating
two
endogenous
antioxidant
enzymes
fabricated.
With
such
dual
anti-ROS
effect,
nanozyme
robustly
decreases
cellular
effectively
protects
them
from
ROS-induced
injury.
STAT-3
signaling
found
play
vital
role
pDA-MNOF
activating
the
enzymes,
HO1
SOD2.
In
vivo
treatment
improves
survival
middle
cerebral
artery
occlusion
(MCAo)
mice
reducing
infarct
volume
more
importantly,
promotes
animal
behavioral
recovery.
Further,
activates
vascular
endothelial
growth
factor
expression,
downstream
target
STAT3
signaling,
thus
enhancing
angiogenesis.
Taken
together,
biochemical,
cell-biological,
animal-level
data
demonstrate
potentiality
as
ROS-scavenging
agent
for
treatment.
ACS Nano,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 24, 2024
Overproduction
of
reactive
oxygen
species
by
damaged
mitochondria
after
ischemia
is
a
key
factor
in
the
subsequent
cascade
damage.
Delivery
therapeutic
agents
to
neurons
brain
potentially
promising
targeted
strategy
for
treatment
ischemic
stroke.
In
this
study,
we
developed
ceria
nanoenzymes
synergistic
drug-carrying
nanosystem
targeting
address
multiple
factors
Each
component
works
individually
as
well
synergistically,
resulting
comprehensive
therapy.
Alleviation
oxidative
stress
and
modulation
mitochondrial
microenvironment
into
favorable
state
tolerance
are
combined
restore
bridging
injuries.
This
work
also
revealed
detailed
mechanisms
which
proposed
nanodelivery
system
protects
brain,
represents
paradigm
shift
stroke
treatment.